Renal function and attributable risk of death and cardiovascular hospitalization in participants with diabetes from a registry-based cohort

• A eGFR<90mL/min/1.73m2 was associated with increased mortality risk (p <0.001). • A eGFR<90mL/min/1.73m2 was associated with increased hospitalizations (p <0.001). • Mortality estimated PAR associated with eGFR levels<60 was significant in DM. • Mortality estimated PAR associated wi...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:A pilot randomized controlled trial examining the feasibility, acceptability, and efficacy of Adapted Motivational Interviewing for post-operative bariatric surgery patients. - 2016. - Amsterdam [u.a.]
1. Verfasser: Ruiz-Quintero, Manuel (VerfasserIn)
Weitere Verfasser: Redón, Josep (BerichterstatterIn), Téllez-Plaza, María (BerichterstatterIn), Cebrián-Cuenca, Ana M. (BerichterstatterIn), Navarro-Pérez, Jorge (BerichterstatterIn), Menéndez, Edelmiro (BerichterstatterIn), Perez-Navarro, Ana (BerichterstatterIn), Fernández-Giménez, Antonio (BerichterstatterIn), López-Pineda, Adriana (BerichterstatterIn), Quesada, José A. (BerichterstatterIn), Pallares-Carratalá, Vicente (BerichterstatterIn), Gil-Guillen, Vicente F. (BerichterstatterIn), Martin-Moreno, José M. (BerichterstatterIn), Bleda-Cano, Jesús (BerichterstatterIn), Carrascosa, Sara (BerichterstatterIn), Carratalá-Munuera, Concepción (BerichterstatterIn)
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2021
Zugriff auf das übergeordnete Werk:A pilot randomized controlled trial examining the feasibility, acceptability, and efficacy of Adapted Motivational Interviewing for post-operative bariatric surgery patients
Schlagworte:Hypertension Attributable risk Diabetes mellitus Mortality Kidney dysfunction Cardiovascular diseases
Umfang:7
LEADER 01000caa a22002652 4500
001 ELV052596745
003 DE-627
005 20230624184845.0
007 cr uuu---uuuuu
008 210910s2021 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.pcd.2020.06.004  |2 doi 
028 5 2 |a /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001249.pica 
035 |a (DE-627)ELV052596745 
035 |a (ELSEVIER)S1751-9918(20)30216-3 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
082 0 4 |a 630  |q VZ 
082 0 4 |a 640  |q VZ 
082 0 4 |a 590  |q VZ 
082 0 4 |a 610  |q VZ 
082 0 4 |a 600  |q VZ 
084 |a 50.70  |2 bkl 
100 1 |a Ruiz-Quintero, Manuel  |e verfasserin  |4 aut 
245 1 0 |a Renal function and attributable risk of death and cardiovascular hospitalization in participants with diabetes from a registry-based cohort 
264 1 |c 2021 
300 |a 7 
336 |a nicht spezifiziert  |b zzz  |2 rdacontent 
337 |a nicht spezifiziert  |b z  |2 rdamedia 
338 |a nicht spezifiziert  |b zu  |2 rdacarrier 
520 |a • A eGFR<90mL/min/1.73m2 was associated with increased mortality risk (p <0.001). • A eGFR<90mL/min/1.73m2 was associated with increased hospitalizations (p <0.001). • Mortality estimated PAR associated with eGFR levels<60 was significant in DM. • Mortality estimated PAR associated with eGFR levels<60 was significant in CVD. 
650 7 |a Hypertension  |2 Elsevier 
650 7 |a Attributable risk  |2 Elsevier 
650 7 |a Diabetes mellitus  |2 Elsevier 
650 7 |a Mortality  |2 Elsevier 
650 7 |a Kidney dysfunction  |2 Elsevier 
650 7 |a Cardiovascular diseases  |2 Elsevier 
700 1 |a Redón, Josep  |4 oth 
700 1 |a Téllez-Plaza, María  |4 oth 
700 1 |a Cebrián-Cuenca, Ana M.  |4 oth 
700 1 |a Navarro-Pérez, Jorge  |4 oth 
700 1 |a Menéndez, Edelmiro  |4 oth 
700 1 |a Perez-Navarro, Ana  |4 oth 
700 1 |a Fernández-Giménez, Antonio  |4 oth 
700 1 |a López-Pineda, Adriana  |4 oth 
700 1 |a Quesada, José A.  |4 oth 
700 1 |a Pallares-Carratalá, Vicente  |4 oth 
700 1 |a Gil-Guillen, Vicente F.  |4 oth 
700 1 |a Martin-Moreno, José M.  |4 oth 
700 1 |a Bleda-Cano, Jesús  |4 oth 
700 1 |a Carrascosa, Sara  |4 oth 
700 1 |a Carratalá-Munuera, Concepción  |4 oth 
773 0 8 |i Enthalten in  |n Elsevier  |a David, Lauren A. ELSEVIER  |t A pilot randomized controlled trial examining the feasibility, acceptability, and efficacy of Adapted Motivational Interviewing for post-operative bariatric surgery patients  |d 2016  |g Amsterdam [u.a.]  |w (DE-627)ELV024210129 
773 1 8 |g volume:15  |g year:2021  |g number:1  |g pages:88-94  |g extent:7 
856 4 0 |u https://doi.org/10.1016/j.pcd.2020.06.004  |3 Volltext 
912 |a GBV_USEFLAG_U 
912 |a GBV_ELV 
912 |a SYSFLAG_U 
912 |a GBV_ILN_24 
912 |a GBV_ILN_40 
912 |a GBV_ILN_60 
912 |a GBV_ILN_72 
912 |a GBV_ILN_227 
912 |a GBV_ILN_350 
936 b k |a 50.70  |j Energie: Allgemeines  |q VZ 
951 |a AR 
952 |d 15  |j 2021  |e 1  |h 88-94  |g 7